Hypocretins and primary headaches: neurobiology and clinical implications

References

• De Lecea L, Kilduff TS, Peyron C et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl Acad. Sci. USA95, 322–327 (1998).
   PubMed Web of Science ®Google Scholar
• Sakurai T, Amemiya A, Ishii M et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell92, 573–585 (1998).
   PubMed Web of Science ®Google Scholar
• Nishino S. The hypocretin/orexin system in health and disease. Biol. Psychiatry54, 87–95 (2003).
   PubMed Web of Science ®Google Scholar
• Kukkonen JP, Holmqvist T, Ammoun S, Akerman KE. Functions of the orexinergic/hypocretinergic system. Am. J. Physiol. Cell Physiol.283, C1567–C1591 (2002).
   PubMed Web of Science ®Google Scholar
• Shibahara M, Sakurai T, Nambu T et al. Structure, tissue distribution, and pharmacological characterization of Xenopusorexins. Peptides20, 1169–1176 (1999).
   PubMedGoogle Scholar
• Narita M, Nagumo Y, Miyatake M, Ikegami D, Kurahashi K, Suzuki T. Implication of protein kinase C in the orexin-induced elevation of extracellular dopamine levels and its rewarding effect. Eur. J. Neurosci.25, 1537–1545 (2007).
   PubMedGoogle Scholar
• Cheng SB, Kuchiiwa S, Gao HZ, Kuchiiwa T, Nakagawa S. Morphological study of orexin neurons in the hypothalamus of the Long-Evans rat, with special reference to co-expression of orexin and NADPH-diaphorase or nitric oxide synthase activities. Neurosci. Res.46, 53–62 (2003).
   PubMedGoogle Scholar
• Peyron C, Tighe DK, Van Den Pol AN et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J. Neurosci.18, 9996–10015 (1998).
   PubMed Web of Science ®Google Scholar
• Monda M, Viggiano A, De Luca V. Paradoxical effect of orexin A: the hypophagia induced by hyperthermia. Brain Res.961, 220–228 (2003).
   PubMed Web of Science ®Google Scholar
• Yamanaka A, Sakurai T, Katsumoto T, Yanagisawa M, Goto K. Chronic intracerebroventricular administration of orexin-A to rats increases food intake in daytime, but has no effect on body weight. Brain Res.849, 248–252 (1999).
   PubMed Web of Science ®Google Scholar
• Piper DC, Upton N, Smith MI, Hunter AJ. The novel brain neuropeptide, orexin-A, modulates the sleep-wake cycle of rats. Eur. J. Neurosci.12, 726–730 (2000).
   PubMed Web of Science ®Google Scholar
• Date Y, Ueta Y, Yamashita H et al. Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proc. Natl Acad. Sci. USA96, 748–753 (1999).
   PubMed Web of Science ®Google Scholar
• Monda M, Viggiano A, Viggiano A et al. Sympathetic and hyperthermic reactions by orexin A: role of cerebral catecholaminergic neurons. Regul. Pept.139, 39–44 (2007).
   PubMedGoogle Scholar
• Berthoud HR, Patterson LM, Sutton C, Morrison C, Zheng H. Orexin inputs to caudal raphé nucleus involved in thermal, cardiovascular, and gastrointestinal regulation. Histochem. Cell Biol.123, 147–156 (2005).
   PubMedGoogle Scholar
• Yoshimichi H, Yoshimatsu T, Masaki T, Sakata T. Orexin-A regulates body temperature in coordination with arousal status. Exp. Biol. Med. (Maywood)226, 468–476 (2001).
   PubMed Web of Science ®Google Scholar
• Harris GC, Wimmer M, Aston-Jones G. A role for lateral hypothalamic orexin neurons in reward seeking. Nature437, 556–559 (2005).
   PubMed Web of Science ®Google Scholar
• Cutler DJ, Morris R, Sheridhar V et al. Differential distribution of orexin-A and orexin-B immunoreactivity in the rat brain and spinal cord. Peptides20, 1455–1470 (1999).
   PubMed Web of Science ®Google Scholar
• Hamba M. Effects of lesion and stimulation of rat hypothalamic arcuate nucleus on the pain system. Brain Res. Bull.21, 757–763 (1988).
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Nozaki-Taguchi N, Chiba T. Analgesic effect of intrathecally administered orexin-A in the rat formalin test and in the rat hot plate test. Br. J. Pharmacol.137, 170–176 (2002).
   PubMed Web of Science ®Google Scholar
• Suyama H, Kawamoto M, Shiraishi S et al. Analgesic effect of intrathecal administration of orexin on neuropathic pain in rats. In vivo18, 119–123 (2004).
   PubMed Web of Science ®Google Scholar
• Holland PR, Akerman S, Goadsby PJ. Modulation of nociceptive dural input to the trigeminal nucleus caudalis via activation of the orexin 1 receptor in the rat. Eur. J. Neurosci.24, 2825–2833 (2006).
   PubMed Web of Science ®Google Scholar
• Watanabe S, Kuwaki T, Yanagisawa M, Fukuda Y, Shimoyama M. Persistent pain and stress activate pain-inhibitory orexin pathways. Neuroreport16, 5–8 (2005).
   PubMed Web of Science ®Google Scholar
• Bartsch T, Levy MJ, Knight YE, Goadsby PJ. Differential modulation of nociceptive dural input to [hypocretin] orexin A and B receptor activation in the posterior hypothalamic area. Pain109, 367–378 (2004).
   PubMed Web of Science ®Google Scholar
• Hungs M, Fan J, Lin L, Lin X, Maki RA, Mignot E. Identification and functional analysis of mutations in the hypocretin (orexin) genes of narcoleptic canines. Genome Res.11, 531–539 (2001).
   PubMed Web of Science ®Google Scholar
• Willie JT, Chemelli RM, Sinton CM et al. Distinct narcolepsy syndromes in orexin receptor-2 and orexin null mice: molecular genetic dissection of non-REM and REM sleep regulatory processes. Neuron38, 715–730 (2003).
   PubMed Web of Science ®Google Scholar
• Willie JT, Renthal W, Chemelli RM et al. Modafinil more effectively induces wakefulness in orexin-null mice than in wild-type littermates. Neuroscience130, 983–985 (2005).
   PubMed Web of Science ®Google Scholar
• Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet355, 39–40 (2000).
   PubMed Web of Science ®Google Scholar
• Thannickal TC, Moore RY, Nienhuis R et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron27, 469–474 (2000).
   PubMed Web of Science ®Google Scholar
• Mignot E, Lammers GJ, Ripley B et al. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch. Neurol.59, 1553–1562 (2002).
   PubMed Web of Science ®Google Scholar
• Fronczek R, Overeem S, Lee SY et al. Hypocretin (orexin) loss in Parkinson’s disease. Brain130, 1577–1585 (2007).
   PubMed Web of Science ®Google Scholar
• Ripley B, Overeem S, Fujiki N et al. CSF hypocretin/orexin levels in narcolepsy and other neurological conditions. Neurology57, 2253–2258 (2001).
   PubMed Web of Science ®Google Scholar
• Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 2nd Edition. Cephalalgia24(1 Suppl. 1), 1–152 (2004).
   Web of Science ®Google Scholar
• Lipton RB, Bigal ME, Diamond ML et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology68, 343–349 (2007).
   PubMed Web of Science ®Google Scholar
• MC Kruit MA, van Buchem, Hofman PA et al. Migraine as a risk factor for subclinical brain lesions. JAMA291, 427–434 (2004).
   PubMedGoogle Scholar
• Goadsby PJ, Lipton RB, Ferrari MD. Migraine – current understanding and treatment. N. Engl. J. Med.346, 257–270 (2002).
   PubMed Web of Science ®Google Scholar
• Menken M, Munsat TL, Toole JF. The global burden of disease study: implications for neurology. Arch. Neurol.57, 418–420 (2000).
   PubMed Web of Science ®Google Scholar
• Andlin-Sobocki P, Jönsson B, Wittchen HU, Olesen J. Cost of disorders of the brain in Europe. Eur. J. Neurol.12(Suppl. 1), 1–27 (2005).
   PubMed Web of Science ®Google Scholar
• D’Amico D, Usai S, Grazzi L et al. Quality of life and disability in primary chronic daily headaches. Neurol. Sci.2(Suppl. 2), S97–S100 (2003).
   Google Scholar
• Goadsby PJ. Pathophysiology of cluster headache: a trigeminal autonomic cephalgia. Lancet Neurol.1, 251–257 (2002).
   PubMed Web of Science ®Google Scholar
• De Simone R, Marano E, Ranieri A, Bonavita V. Hypnic headache: an update. Neurol. Sci.27(Suppl. 2), S144–S148 (2006).
   PubMed Web of Science ®Google Scholar
• Edvinsson L, Uddman R. Neurobiology in primary headaches. Brain Res. Brain Res. Rev.48, 438–456 (2004).
   PubMedGoogle Scholar
• Denuelle M, Fabre N, Payoux P, Chollet F, Geraud G. Hypothalamic activation in spontaneous migraine attacks. Headache47, 1418–1426 (2007).
   PubMed Web of Science ®Google Scholar
• May A, Bahra A, Buchel C, Frackowiak RS, Goadsby PJ. Hypothalamic activation in cluster headache attacks. Lancet352, 275–278 (1998).
   PubMed Web of Science ®Google Scholar
• May A, Ashburner J, Büchel C et al. Correlation between structural and functional changes in brain in an idiopathic headache syndrome. Nat. Med.5, 836–838 (1999).
   PubMed Web of Science ®Google Scholar
• Matharu MS, Cohen AS, Frackowiak RS, Goadsby PJ. Posterior hypothalamic activation in paroxysmal hemicrania. Ann. Neurol.59, 535–545 (2006).
   PubMed Web of Science ®Google Scholar
• Alstadhaug KB, Bekkelund S, Salvesen R. Circannual periodicity of migraine? Eur. J. Neurol.14, 983–988 (2007).
   PubMed Web of Science ®Google Scholar
• Pringsheim T. Cluster headache: evidence for a disorder of circadian rhythm and hypothalamic function. Can. J. Neurol. Sci.29, 33–40 (2002).
   PubMedGoogle Scholar
• Abrahamson EE, Leak RK, Moore RY. The posterior hypothalamic area: chemoarchitecture and afferent connections. Brain Res.889, 1–22 (2001).
   PubMedGoogle Scholar
• Rainero I, Gallone S, Valfre W et al. A polymorphism of the hypocretin receptor 2 gene is associated with cluster headache. Neurology63, 1286–1288 (2004).
   PubMed Web of Science ®Google Scholar
• Schurks M, Kurth T, Geissler I, Tessmann G, Diener HC, Rosskopf D. Cluster headache is associated with the G1246A polymorphism in the hypocretin receptor 2 gene. Neurology66, 1917–1919 (2006).
   PubMed Web of Science ®Google Scholar
• Baumber L, Sjostrand C, Leone M et al. A genome-wide scan and HCRTR2 candidate gene analysis in a European cluster headache cohort. Neurology66, 1888–1893 (2006).
   PubMed Web of Science ®Google Scholar
• Rainero I, Rubino E, Valfrè W et al. Association between the G1246A polymorphism of the hypocretin receptor 2 gene and cluster headache: a meta-analysis. J. Headache Pain8, 152–156 (2007).
   PubMed Web of Science ®Google Scholar
• Schurks M, Kurth T, Geissler I, Tessmann G, Diener HC, Rosskopf D. The G1246A polymorphism in the hypocretin receptor 2 gene is not associated with treatment response in cluster headache. Cephalalgia27, 363–367 (2007).
   PubMed Web of Science ®Google Scholar
• Paemeleire K, Bahra A, Evers S, Matharu MS, Goadsby PJ. Medication-overuse headache in patients with cluster headache. Neurology67, 109–113 (2006).
   PubMedGoogle Scholar
• Schürks M, Limmroth V, Geissler I et al. Association between migraine and the G1246A polymorphism in the hypocretin receptor 2 gene. Headache47, 1195–1199 (2007).
   PubMedGoogle Scholar
• Pinessi L, Binello E, De Martino P et al. The 1246 G>A polymorphism of the HCRTR2 gene is not associated with migraine. Cephalagia27, 945–949 (2007).
   PubMedGoogle Scholar
• Bigal ME, Lipton RB, Holland PR, Goadsby PJ. Obesity, migraine, and chronic migraine: possible mechanisms of interaction. Neurology68, 1851–1861 (2007).
   PubMed Web of Science ®Google Scholar
• Sarchielli P, Rainero I, Coppola F et al. Involvement of corticotrophin-releasing factor and orexin-A in chronic migraine and medication-overuse headache: findings from cerebrospinal fluid. Cephalagia (2008) (In press).
   PubMedGoogle Scholar